Form 4: Health Catalyst Director, Julie Larson-Green, Reports Acquisition of 1,950 Shares Through RSU Vesting

Julie Larson-Green, a director at Health Catalyst, Inc., acquired 1,950 shares of common stock on September 1, 2024, through the vesting of restricted stock units (RSUs).

Summary

• On September 1, 2024, Julie Larson-Green, a director of Health Catalyst, Inc., acquired 1,950 shares of common stock.
• This acquisition resulted from the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
• The RSUs vested fully on September 1, 2024, according to the terms of the plan and the Non-Employee Director Compensation Policy.
• Following the transaction, Larson-Green directly owns 67,188 shares of Health Catalyst common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating alignment of interests with shareholders.

Positives

• The vesting of RSUs indicates that the director has met certain performance or time-based milestones set by the company.
• The director's increased stake in the company aligns her interests with those of other shareholders.

Industry Context

Director share acquisitions are common and often tied to compensation plans designed to align management interests with shareholder value. This transaction is a routine part of director compensation.

Comparison to Industry Standards

• Director compensation packages often include stock options and RSUs to incentivize long-term performance.
• The vesting schedule and terms are typical for director compensation plans in publicly traded companies.
• Similar companies like Cerner (now Oracle Health) and Allscripts also use equity-based compensation for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates